Skip to main content

Rani Therapeutics

San Jose, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

$60.3M raised
Oct 2025
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rani Therapeutics

How much funding has Rani Therapeutics raised?
Rani Therapeutics has raised $60.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Who are Rani Therapeutics's investors?
Rani Therapeutics's investors include RA Capital Management, Novartis, AstraZeneca, Samsara BioCapital, Invus.
Where is Rani Therapeutics headquartered?
Rani Therapeutics is headquartered in San Jose, United States.
What does Rani Therapeutics do?
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
What stage is Rani Therapeutics at?
Rani Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Rani Therapeutics — Funding & Investors." VCBacked, October 17, 2025, https://www.vcbacked.co/company/rani-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Rani Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/rani-therapeutics
Wikipedia (cite web)
{{cite web |title=Rani Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rani-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .